Literature DB >> 18532922

Novel vesicular and particulate drug delivery systems for topical treatment of acne.

Gisele A Castro1, Lucas Am Ferreira.   

Abstract

BACKGROUND: The efficacy of the antiacne topical drugs is well established. The local side effects, however, mainly cutaneous irritation, erythema, dryness, peeling and scaling, remain major problems. Novel vesicular and particulate drug delivery systems have been proposed to reduce the side effects of drugs commonly used in the topical treatment of acne.
OBJECTIVE: This review focuses on the development and evaluation of antiacne drug-loaded vesicular and particulate delivery systems (liposomes, polymeric microspheres and solid lipid nanoparticles) for topical treatment, their advantages and challenges.
METHODS: All the literature available was reviewed to highlight the potential of these novel systems for the topical treatment of acne.
CONCLUSION: The encapsulation of antiacne drugs in vesicular and particulate delivery systems represents an innovative alternative to minimize side effects, while preserving their efficacy. This can be obtained by the capacity of these systems to provide controlled release or to improve the drug penetration into skin or even into the pilosebaceous unit.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18532922     DOI: 10.1517/17425247.5.6.665

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  16 in total

Review 1.  Nanoparticles and nanofibers for topical drug delivery.

Authors:  Ritu Goyal; Lauren K Macri; Hilton M Kaplan; Joachim Kohn
Journal:  J Control Release       Date:  2015-10-28       Impact factor: 9.776

Review 2.  Emerging Issues in Adult Female Acne.

Authors:  Joshua A Zeichner; Hillary E Baldwin; Fran E Cook-Bolden; Lawrence F Eichenfield; Sheila Fallon-Friedlander; David A Rodriguez
Journal:  J Clin Aesthet Dermatol       Date:  2017-01-01

3.  Bacterial toxin-triggered drug release from gold nanoparticle-stabilized liposomes for the treatment of bacterial infection.

Authors:  Dissaya Pornpattananangkul; Li Zhang; Sage Olson; Santosh Aryal; Marygorret Obonyo; Kenneth Vecchio; Chun-Ming Huang; Liangfang Zhang
Journal:  J Am Chem Soc       Date:  2011-02-23       Impact factor: 15.419

Review 4.  Engineering nanomedicines for improved melanoma therapy: progress and promises.

Authors:  Di Bei; Jianing Meng; Bi-Botti C Youan
Journal:  Nanomedicine (Lond)       Date:  2010-11       Impact factor: 5.307

5.  Stimuli-responsive liposome fusion mediated by gold nanoparticles.

Authors:  Dissaya Pornpattananangkul; Sage Olson; Santosh Aryal; Marta Sartor; Chun-Ming Huang; Kenneth Vecchio; Liangfang Zhang
Journal:  ACS Nano       Date:  2010-04-27       Impact factor: 15.881

6.  The antimicrobial activity of liposomal lauric acids against Propionibacterium acnes.

Authors:  Darren Yang; Dissaya Pornpattananangkul; Teruaki Nakatsuji; Michael Chan; Dennis Carson; Chun-Ming Huang; Liangfang Zhang
Journal:  Biomaterials       Date:  2009-08-08       Impact factor: 12.479

7.  Eradication of drug resistant Staphylococcus aureus by liposomal oleic acids.

Authors:  Chun-Ming Huang; Chao-Hsuan Chen; Dissaya Pornpattananangkul; Li Zhang; Michael Chan; Ming-Fa Hsieh; Liangfang Zhang
Journal:  Biomaterials       Date:  2010-09-28       Impact factor: 12.479

8.  Acid-responsive polymeric nanocarriers for topical adapalene delivery.

Authors:  Chenchen Guo; Rajeshree H Khengar; Mingjing Sun; Zheng Wang; Aiping Fan; Yanjun Zhao
Journal:  Pharm Res       Date:  2014-05-08       Impact factor: 4.200

9.  Nanoparticle-stabilized liposomes for pH-responsive gastric drug delivery.

Authors:  Soracha Thamphiwatana; Victoria Fu; Jingying Zhu; Diannan Lu; Weiwei Gao; Liangfang Zhang
Journal:  Langmuir       Date:  2013-09-16       Impact factor: 3.882

10.  Oral Bioavailability Improvement of Tailored Rosuvastatin Loaded Niosomal Nanocarriers to Manage Ischemic Heart Disease: Optimization, Ex Vivo and In Vivo Studies.

Authors:  Kun Liao; Na Tang; Qiang Liu; Jing Xu
Journal:  AAPS PharmSciTech       Date:  2021-01-27       Impact factor: 4.026

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.